How we treat primary central nervous system lymphoma

MYD88 L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study

(2021) Andrés J. M. Ferreri et al.   BRITISH JOURNAL OF HAEMATOLOGY

CXCR4-targeted positron emission tomography imaging of central nervous system B-cell lymphoma

(2020) Peter Herhaus et al.   JOURNAL OF NUCLEAR MEDICINE

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study

(2019) Jacoline E C Bromberg et al.   LANCET ONCOLOGY

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study

(2019) Caroline Houillier et al.   JOURNAL OF CLINICAL ONCOLOGY

Tisagenlecleucel CAR-T Cell Therapy in Secondary CNS Lymphoma

(2019) Matthew J. Frigault et al.   BLOOD

Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network

(2019) C. Soussain et al.   EUROPEAN JOURNAL OF CANCER

Phase I study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreo-retinal lymphoma

(2018) Han W. Tun et al.   BLOOD

Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma

(2017) Christian Grommes et al.   Cancer Discovery

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

(2017) Andrés J M Ferreri et al.   Lancet Haematology

Trends in primary central nervous system lymphoma incidence and survival in the U.S.

(2016) Meredith S. Shiels et al.   BRITISH JOURNAL OF HAEMATOLOGY

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)

(2016) K Fritsch et al.   LEUKEMIA

Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial

(2015) Antonio Omuro et al.   Lancet Haematology

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by The Nordic Lymphoma Group

(2014) E. J. Pulczynski et al.   HAEMATOLOGICA

Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

(2013) Patrick G. Morris et al.   JOURNAL OF CLINICAL ONCOLOGY